Healthcare >> CEO Interviews >> April 5, 2010

Aeterna Zentaris, Inc. – Jurgen Engel, Ph.d.

TWST: Introduce us to AEterna Zentaris.

Dr. Engel: AEterna Zentaris (AEZS) is a late-stage drug development company specialized in oncology and endocrinology, with a robust and balanced pipeline. We